Osteoporosis. Osteoporosis in postmenopausal women
Conditions
Interventions
Intervention 1: experimental group receive daily 8/0 unit hypodermic insulin syringe from Cinnopar for six month.
and daily receive 1000mg calcium and 400 unit edible vitaminD tablets for six month. I
Treatment - Drugs
experimental group receive daily 8/0 unit hypodermic insulin syringe from Cinnopar for six month.
and daily receive 1000mg calcium and 400 unit edible vitaminD tablets for six month
control group daily receive 1000mg calcium and 400 unit edible vitaminD tablets for six month
Sponsors
Vice Chancellor for Research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Postmenopausal women (aged 45 to 75 years old) diagnosed with osteoporosis by densitometry via Dexa(dual energy Xray absorptiometry); who do not have any history of treatment for osteoporosis; and consent to participate in the study were recruited into the study. Exclusion criteria: Women with a history of taking corticosteroids or any other medications which cause osteoporosis ; hyperparathyroidism.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone density. Timepoint: Before treatment and six months after treatment. Method of measurement: densitometry test through Dexa(dual energy Xray absorptiometry.;Serum levels of calcium. Timepoint: Before treatment and six months after treatment. Method of measurement: blood test.;Phosphor level. Timepoint: Before treatment and six months after treatment. Method of measurement: blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fractures. Timepoint: One year. Method of measurement: Radiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor Masoud Shayesteh Azar
Mazandaran University of Medical Sciences
Outcome results
None listed